Immunoglobulin A Antibodies: From Protection to Harmful Roles

Overview

Journal Immunol Rev

Specialties Allergy & Immunology
General Surgery

Date 2024 Nov 23

PMID 39578936

Authors

Patrick J Gleeson

Niels O S Camara

Pierre Launay

Agnes Lehuen

Renato C Monteiro

Affiliations

Soon will be listed here.

Abstract

Immunoglobulin A (IgA) is the most abundantly produced antibody in humans. IgA is a unique class of immunoglobulin due to its multiple molecular forms, and a defining difference between the two subclasses: IgA1 has a long hinge-region that is heavily O-glycosylated, whereas the IgA2 hinge-region is shorter but resistant to bacterial proteases prevalent at mucosal sites. IgA is essential for immune homeostasis and education. Mucosal IgA plays a crucial role in maintaining the integrity of the mucosal barrier by immune exclusion of pathobionts while facilitating colonization with certain commensals; a large part of the gut microbiota is coated with IgA. In the circulation, monomeric IgA that has not been engaged by antigen plays a discrete role in dampening inflammatory responses. Protective and harmful roles of IgA have been studied over several decades, but a new understanding of the complex role of this immunoglobulin in health and disease has been provided by recent studies. Here, we discuss the physiological and pathological roles of IgA with a special focus on the gut, kidneys, and autoimmunity. We also discuss new IgA-based therapeutic approaches.

References

Rojas O, Probstel A, Porfilio E, Wang A, Charabati M, Sun T . Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10. Cell. 2019; 176(3):610-624.e18. PMC: 6903689. DOI: 10.1016/j.cell.2018.11.035. View

Roy M, Varvayanis M . Development of dome epithelium in gut-associated lymphoid tissues: association of IgA with M cells. Cell Tissue Res. 1987; 248(3):645-51. DOI: 10.1007/BF00216495. View

Grey H, Abel C, Yount W, KUNKEL H . A subclass of human gamma-A-globulins (gamma-A2) which lacks the disulfied bonds linking heavy and light chains. J Exp Med. 1968; 128(6):1223-36. PMC: 2138581. DOI: 10.1084/jem.128.6.1223. View

Torigoe C, INMAN J, Metzger H . An unusual mechanism for ligand antagonism. Science. 1998; 281(5376):568-72. DOI: 10.1126/science.281.5376.568. View

Lamberts A, Euverman H, Terra J, Jonkman M, Horvath B . Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases. Front Immunol. 2018; 9:248. PMC: 5827539. DOI: 10.3389/fimmu.2018.00248. View

Hendrickson B, Conner D, Ladd D, Kendall D, Casanova J, Corthesy B . Altered hepatic transport of immunoglobulin A in mice lacking the J chain. J Exp Med. 1995; 182(6):1905-11. PMC: 2192233. DOI: 10.1084/jem.182.6.1905. View

Balu S, Reljic R, Lewis M, Pleass R, McIntosh R, van Kooten C . A novel human IgA monoclonal antibody protects against tuberculosis. J Immunol. 2011; 186(5):3113-9. PMC: 3115510. DOI: 10.4049/jimmunol.1003189. View

Hansen I, Krabbendam L, Bernink J, Loayza-Puch F, Hoepel W, van Burgsteden J . FcαRI co-stimulation converts human intestinal CD103 dendritic cells into pro-inflammatory cells through glycolytic reprogramming. Nat Commun. 2018; 9(1):863. PMC: 5830413. DOI: 10.1038/s41467-018-03318-5. View

Malbec O, Cassard L, Albanesi M, Jonsson F, Mancardi D, Chicanne G . Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils. Sci Signal. 2016; 9(459):ra126. DOI: 10.1126/scisignal.aag1401. View

10.

Pabst O . New concepts in the generation and functions of IgA. Nat Rev Immunol. 2012; 12(12):821-32. DOI: 10.1038/nri3322. View

11.

Mantis N, Cheung M, Chintalacharuvu K, Rey J, Corthesy B, Neutra M . Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J Immunol. 2002; 169(4):1844-51. DOI: 10.4049/jimmunol.169.4.1844. View

12.

Cerutti A, Rescigno M . The biology of intestinal immunoglobulin A responses. Immunity. 2008; 28(6):740-50. PMC: 3057455. DOI: 10.1016/j.immuni.2008.05.001. View

13.

Pinheiro A, de Sousa-Pereira P, Strive T, Knight K, Woof J, Esteves P . Identification of a new European rabbit IgA with a serine-rich hinge region. PLoS One. 2018; 13(8):e0201567. PMC: 6082545. DOI: 10.1371/journal.pone.0201567. View

14.

Wilson T, Fuchs A, Colonna M . Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J Immunol. 2012; 188(10):4741-5. PMC: 3634363. DOI: 10.4049/jimmunol.1102651. View

15.

Mazanec M, Nedrud J, Kaetzel C, Lamm M . A three-tiered view of the role of IgA in mucosal defense. Immunol Today. 1993; 14(9):430-5. DOI: 10.1016/0167-5699(93)90245-G. View

16.

Woof J, Kerr M . The function of immunoglobulin A in immunity. J Pathol. 2005; 208(2):270-82. DOI: 10.1002/path.1877. View

17.

Torano A, TSUZUKIDA Y, Liu Y, Putnam F . Location and structural significance of the oligosaccharides in human Ig-A1 and IgA2 immunoglobulins. Proc Natl Acad Sci U S A. 1977; 74(6):2301-5. PMC: 432158. DOI: 10.1073/pnas.74.6.2301. View

18.

Shinkura R . Therapeutic immunoglobulin A antibody for dysbiosis-related diseases. Int Immunol. 2021; 33(12):787-790. PMC: 8499904. DOI: 10.1093/intimm/dxab066. View

19.

Singh G, Brass A, Knight C, Cruickshank S . Gut eosinophils and their impact on the mucus-resident microbiota. Immunology. 2019; 158(3):194-205. PMC: 6797872. DOI: 10.1111/imm.13110. View

20.

Huang Y, Wright A, Gao X, Kulick L, Yan H, Lamm M . Intraepithelial cell neutralization of HIV-1 replication by IgA. J Immunol. 2005; 174(8):4828-35. DOI: 10.4049/jimmunol.174.8.4828. View